Alan M. Solinger

2.8k citations
36 papers · 1.8k · 1 hit paper · h-index 21

Impact in

    • Spondyloarthritis Studies and Treatments
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Immunology top 5%
    • Psoriasis: Treatment and Pathogenesis

Papers in

    • T-cell and B-cell Immunology 3
    • Immune Cell Function and Interaction 3
    • Spondyloarthritis Studies and Treatments 4
    • Systemic Lupus Erythematosus Research 4

Alan M. Solinger

36 papers receiving 1.7k citations

Alan M. Solinger's Hit Papers

Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study 2018 · 288 citations
2880+2+5Years since publication50100150200250

Peers

Alan M. Solinger
Comparison fields: 5 of 89
  • Rheumatology 592
  • Immunology 680
  • Hematology 306
  • Dermatology 151
  • Ophthalmology 144
Replace James A. Goeken with:
James A. Goeken United States
Anne Nicholls United Kingdom
Fatma Dedeoğlu United States
Naoto Tamura Japan
Michael Seitz Switzerland
Shigeto Tohma Japan
Line Nielsen Denmark
Kieron Leslie United States
Gisela Bonsmann Germany
Mindy S. Lo United States
Alan M. Solinger relative to James A. Goeken United States James A. Goeken's profile →
Citations per field
00.5×5.3×
James A. Goeken · 1×
Citations per year

Countries citing papers authored by Alan M. Solinger

Since Specialization
Citations

This map shows the geographic impact of Alan M. Solinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan M. Solinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan M. Solinger more than expected).

Fields of papers citing papers by Alan M. Solinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan M. Solinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan M. Solinger. The network helps show where Alan M. Solinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Alan M. Solinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alan M. Solinger Line = papers co-authored together Alan M. Solinger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
Hit paper breakdown →
2018288
2 2012230
3 2015196
4 2011177
5 2005114
6 199085
7 198173
8 198168
9 200466
10 198042
11 199238
12
Human immunodeficiency virus infection is not associated with Reiter's syndrome. Data from three large cohort studies.
199234
13
Drug-related lupus. Clinical and etiologic considerations.
198833
14 198730
15
Concomitant medication use in a large, international, multicenter, placebo controlled trial of anakinra, a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis.
200429
16 198826
17 198925
18
Rheumatic diseases and AIDS--is the association real?
199322
19 198821
20 197820

About Alan M. Solinger

Alan M. Solinger is a scholar working on Immunology, Rheumatology, Epidemiology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 36 papers that have together received 1.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Spondyloarthritis Studies and Treatments (4 papers), Systemic Lupus Erythematosus Research (4 papers), T-cell and B-cell Immunology (3 papers), Inflammatory Myopathies and Dermatomyositis (3 papers), Autoimmune Bullous Skin Diseases (3 papers) and Immune Cell Function and Interaction (3 papers). The work is most often cited by research in Rheumatology (592 citations), Immunology (680 citations), Hematology (306 citations), Dermatology (151 citations) and Ophthalmology (144 citations). Alan M. Solinger has collaborated with scholars based in United States, Germany and Denmark. Frequent co-authors include Charles A. Dinarello, Daniel J. Lovell, Suzanne L. Bowyer, Paul Scholl, Steven J. Padula, Stella Aslanyan, Sudha Visvanathan, John D. Stobo, Marc C. Hochberg and Marcus R. Clark. Their work appears in journals such as Rheumatic Disease Clinics of North America, Blood, Annals of the Rheumatic Diseases, Advances in experimental medicine and biology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact